1.Characterization of a species-specific antigen of rickettsia tsutsugamushi isolated in Korea.
Jae Seung KANG ; Byung Uk LIM ; Woo Hyun CHANG
Journal of the Korean Society for Microbiology 1991;26(5):443-450
No abstract available.
Korea*
;
Orientia tsutsugamushi*
;
Rickettsia*
2.DNA sequences of the HLA-DRB1 chain from HLA-DR4 subtype alleles.
Mun Gan RHYU ; Byung Uk LIM ; Gum Ryong KIM
Korean Journal of Immunology 1993;15(1):119-127
No abstract available.
Alleles*
;
Base Sequence*
;
DNA*
;
HLA-DR4 Antigen*
;
HLA-DRB1 Chains*
3.Production of Monoclonal Antibody Against Human 14 - 3 - 3 Zeta Isoform Expressed in Escherichia coli.
Byung Uk LIM ; Jae Seung KANG ; Jung Woo KIM ; Nam Jong CHOI
Korean Journal of Immunology 1997;19(3):391-398
14-3-3 proteins are cytoplasmic proteins of about 29 kDa and have a minimum of seven isoforms. This protein is important in signal transduction with the ability of binding with phosphoserine of many signalling proteins. We expressed 14-3-3 protein tagged with 6 histidine residues in E. coli and purified the protein by nickel affinity chromatography. Using this purified protein as an antigen, we made rabbit antisera and mouse monoclonal antibodies to 14-3-3 zeta isoform. We subcloned cDNA of 14-3-3 zeta isoform derived from HeLa cell lamda gt 11 library into an E. coli expression vector which is designed to express heterologous protein with N- terminal 6 hidtidine tag. BALB/c mice were immunized with purified 14-3-3 protein and the hybridoma clones which produce monoclonal antibodies angainst 14-3-3 protein were selected. These monoclonal antibodies reacted with the recombinant protein expressed in E. coli as well as the 29-kDa native protein in various cell lines. However, they did not immunoprecipitate 14-3-3 protein. The monoclonal antibodies produced in this study can be valuable tools for the identification of the 14-3-3 in signal transduction study.
14-3-3 Proteins
;
Animals
;
Antibodies, Monoclonal
;
Cell Line
;
Chromatography, Affinity
;
Clone Cells
;
Cytoplasm
;
DNA, Complementary
;
Escherichia coli*
;
Escherichia*
;
HeLa Cells
;
Histidine
;
Humans*
;
Hybridomas
;
Immune Sera
;
Mice
;
Nickel
;
Phosphoserine
;
Protein Isoforms
;
Signal Transduction
;
Staphylococcal Protein A
4.HLA-DR genotyping from one drop blood by double PCR.
Hoon HAN ; Jung Bin LEE ; Yeun Jun CHUNG ; Byung Uk LIM
Journal of the Korean Society for Microbiology 1991;26(2):205-214
No abstract available.
HLA-DR Antigens*
;
Polymerase Chain Reaction*
5.HLA-DR genotyping from sperm by double PCR.
Hoon HAN ; Byung Uk LIM ; Yeun Jun CHUNG ; Jung Bin LEE
Korean Journal of Immunology 1991;13(1):89-98
No abstract available.
HLA-DR Antigens*
;
Polymerase Chain Reaction*
;
Spermatozoa*
6.The Expreience of Treatment of Trochanteric Fracture of the Femur
Soo Kyoon RAH ; Chang Uk CHOI ; Hak Hyun KIM ; Chi Soon YOON ; Byung Kil LIM
The Journal of the Korean Orthopaedic Association 1980;15(3):480-486
It has been emphasized that the treatment of choice for the trochantric fracture of the femur is open reduction and rigid internal fixation to reduce complications by early ambulation. The incidence of trochanteric fracture of the femur in the young age group has been considerably increased in recent years because of increased traffic and industrial accidents. The author treated 38 cases of trochanteric fracture of the femur in the year 1974 through 1979, at the Department of Orthopaedic Surgery, School of Medicine, Soon Chun Hyang College. The results were as follows: 1. In sex distribution, 24 out of 38 were males and 14 were females. 16 cases out of 24 male patients were in the age group 20-40 and 9 cases out of 14 female were over 60 years of age. Over all mortality was 7.9%. 2. The numbers of patients of type I and III were 11 cases in each type out of 38 trochanteric fracture. 3. 26 cases out of 38 cases were treated by open reduction and internal fixation and the others were by traction and cast. 4. The applied metal devices were 3 types: Smith-Peterson nail and Thornton or McLaughlin plate, compression hip screw, and multiple pinning. 5. Mean duration of bony union is shorter in the group of open reduction and internal fixation (13 weeks) than the group of traction and cast (15 weeks). The cause of difference is that the 6 out of 9 cases of type IV and V were included in conservative group. 6. The incidece of the complications such as coxa vara, slipping screw, long nail and traction palsy occurred higher in the group fixed with Smith-Peterson nail and plate than the group fixed with compression hip screw.
Accidents, Occupational
;
Coxa Vara
;
Early Ambulation
;
Female
;
Femur
;
Hip
;
Humans
;
Incidence
;
Male
;
Mortality
;
Paralysis
;
Sex Distribution
;
Traction
7.Serotype of rickettsia Tsutsugamushi isolated in Ulsan area.
Jae Seung KANG ; Byung Uk LIM ; Yong Lim KIM ; Dong Chul PARK ; Jun Tack JO ; Jin Kwan LEE
Korean Journal of Infectious Diseases 1992;24(3):179-182
No abstract available.
Orientia tsutsugamushi*
;
Rickettsia*
;
Ulsan*
8.Proliferation of ECV304 cells Infected Persistently with Orientia tsutsugamushi.
Mee Kyung KIM ; Byung Uk LIM ; Jae Seung KANG
Journal of Bacteriology and Virology 2002;32(3):239-246
Orientia tsutsugamushi, the causative agent of scrub typhus, is an obligate intracellular parasite. Previously we have shown that it persistently infect the human endothelial cell line ECV304. In this study, we have investigated the mechanism of in vitro persistent infection, which could be maintained for over a year without addition of normal cells. The persistently infected cultures exhibited cyclic changes in the host cell number, which resulted in a net increase of cell number. Floating cells detached from the culture plate bottom were filled with rickettsial cells and lost normal morphology. Only part of attached EVC304 cells was infected with O. tsutsugamushi. Some of ECV304 cells that still attached to the bottom were free of rickettsial cells. Rickettsial cells in the floating cells could not effectively infect new EVC304 cells while those in the attached cell could infect new cells with high efficiency. Host cells that allowed vigorous rickettsial multiplication and resultantly lost viability, and low of infectivity of the bacteria in the dead cells might have allowed in vitro persistent infection of O. tsutsugamushi.
Apoptosis
;
Bacteria
;
Cell Count
;
Endothelial Cells
;
Humans
;
Orientia tsutsugamushi*
;
Parasites
;
Scrub Typhus
9.The Preventive Effect of Pentoxifylline on the Oleic Acid-Induced Lung Injury.
Min Sung LIM ; Sung Sik KANG ; Jong Uk KIM ; Kyu Tack CHOI ; Pyung Hwan PARK ; Byung Te SUH
Korean Journal of Anesthesiology 1997;33(1):41-49
BACKGROUND: Although exact mechanism of adult respiratory distress syndorme (ARDS) is not known, many evidences suggest that inflammatory mediators such as protease and oxygen radicals may be the final common pathway to the endothelial injury. It is gradually accepted that activated neutrophils play a major role in the process. Pentoxifylline is a methylated xanthine with a wide range of actions that make it theoretically useful in the treatment of ARDS. Studies show that it decreases neutrophil phagocytosis and superoxied production. The aim of this experiment is to determine whether pentoxifylline has a preventive effect on oleic acid-induced lung injury. METHODS: Oleic acid (0.08 ml/kg) was infused in 10 mongrel dogs in order to induce acute lung injury. Pentoxifylline (20 mg/kg) was administered 40 mins before oleic acid injection. The author made a comparative studies on the effects of pentoxifylline on hemodynamics and gas exchange before oleic acid injection and at 15, 30, 45, 60, 90 mins after oleic acid injection. RESULTS: There were not significant changes in mean arterial pressure, cardiac output, systemic vascular resistence, pulmonary wedge pressure intrapulmonary shunt in both groups. There were statistical significance in arterial oxygen tension, pulmonary artery pressure, pulmonary vascular resistance between both groups (p<0.05). CONCLUSIONS: Pentoxifylline is a noteworthy drug that could be a candidate as a therapy to help prevent effect in lung injuries that share a common mechanism with oleic acid-induced lung injury.
Acute Lung Injury
;
Adult
;
Animals
;
Arterial Pressure
;
Cardiac Output
;
Dogs
;
Hemodynamics
;
Humans
;
Lung Injury*
;
Lung*
;
Neutrophils
;
Oleic Acid
;
Oxygen
;
Pentoxifylline*
;
Phagocytosis
;
Pulmonary Artery
;
Pulmonary Wedge Pressure
;
Reactive Oxygen Species
;
Vascular Resistance
;
Xanthine
10.The Clinical Meaning of the Emergence of Viral Breakthrough during Lamivudine Treatment in Patients with Hepatitis B Virus Related Chronic Liver Disease.
Chan Bog PARK ; Hyun Jeung LIM ; Byung Cheol YUN ; Sang Uk LEE ; Byung Hoon HAN
The Korean Journal of Hepatology 2004;10(2):108-116
BACKGROUND/AIMS: Viral breakthrough has been considered a major limitation of lamivudine in the treatment of hepatitis B virus related chronic liver disease. Its clinical meaning has not been thoroughly assessed. METHODS: 64 patients who showed viral breakthrough during lamivudine treatment were retrospectively reviewed. We evaluated the rate of HBeAg seroconversion and hepatic decompensation after viral breakthrough. RESULTS: After viral breakthrough, serum alanine transaminase (ALT) elevation more than 1.2X upper limit of normal (ULN) was noticed in 40 patients (62.5%). Acute flare (serum ALT elevation >X5 ULN, or serum bilirubin >3 mg/dL) occured in 15 patients (23.4%). During the period of follow up (15.0 +/- 9.7 months; range, 0-31 months) since viral breakthrough, decreased serum HBV-DNA level to below the detection limit and serum ALT normalization was seen in 15 patients (23.4%). HBeAg seroconversion was noticed in 7 (13.7%) of a total of 51 HBeAg positive patients at base line; in 4 (15.4%) of 26 patients with non-hepatic failure (chronic hepatitis or Child-Pugh class A liver cirrhosis) at base line; and in 2 (40.0%) of 5 patients with non-hepatic failure at base line and acute flare after viral breakthrough. During this period, terminal hepatic decompensation (Child-Pugh class C) or death was noticed in 9 (90.0%) of 10 patients who had hepatic decompensation (Child-Pugh class B or C) at baseline and acute flare after viral breakthrough. CONCLUSIONS: Acute flare after viral breakthrough seemed to continue during HBeAg seroconversion and rarely developed into terminal hepatic decompensation or death in patients with non-hepatic decompensation at baseline. Its incidence is not only high but lethal to most patients with hepatic decompensation at baseline.
Acute Disease
;
Adult
;
Aged
;
Antiviral Agents/*therapeutic use
;
DNA, Viral/blood
;
English Abstract
;
Female
;
Hepatitis B e Antigens/blood
;
Hepatitis B virus/genetics/isolation & purification
;
Hepatitis B, Chronic/complications/drug therapy/*virology
;
Humans
;
Lamivudine/*therapeutic use
;
Male
;
Middle Aged
;
Reverse Transcriptase Inhibitors/*therapeutic use